Analysis of Pharmacy Cardiac Optimization Clinic for Patients with New Onset Atrial Fibrillation Detected via Cardiac Implantable Electronic Device Clinic

For patients with cardiac implantable electronic devices (CIEDs), arrythmias such as atrial fibrillation (AF) can be detected and actions taken to rapidly assess and initiate treatment where appropriate. Actions include timely initiation of anticoagulation, review of blood pressure, and optimization of cholesterol/lipids to prevent unfavorable outcomes, such as stroke and other cardiovascular complications. Delays to initiating anticoagulation can have devastating consequences. We sought to implement a virtual clinic, where a pharmacist reviews patient referrals from a CIED clinic after detecting AF from the CIED. Anticoagulation choice is determined by patient-specific factors, and a shared patient–provider decision to start oral anticoagulation is made. In addition, blood pressure readings and medications are assessed with lipid-lowering therapies for optimization. A total of 315 patients have been admitted through this clinic and anticoagulated over a two-year span; in addition, 322 successful interventions were made for optimization of cardiac therapy. Rapid initiation of anticoagulation within five days of referral was likely to have reduced unfavorable outcomes, such as stroke and other cardiovascular optimizations, leading to improved patient outcomes.

[1]  V. Paudyal,et al.  Interventions and Impact of Pharmacist-Delivered Services for People Infected with COVID-19: A Systematic Review , 2022, Healthcare.

[2]  J. Robson,et al.  Pharmacist-led multidisciplinary approach in preventing strokes in people with atrial fibrillation , 2022, European Journal of Cardiovascular Nursing.

[3]  Xingming Cai,et al.  Diagnostic Accuracy of the HAS-BLED Bleeding Score in VKA- or DOAC-Treated Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis , 2021, Frontiers in Cardiovascular Medicine.

[4]  Xiaoxi Yao,et al.  Subclinical and Device-Detected Atrial Fibrillation: Pondering the Knowledge Gap: A Scientific Statement From the American Heart Association. , 2019, Circulation.

[5]  S. Antoniou,et al.  Preventing strokes in people with atrial fibrillation by improving ABC , 2019, BMJ open quality.

[6]  D. Atar,et al.  Oral Anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1. , 2019, European heart journal.

[7]  F. Gaita,et al.  Subclinical and Asymptomatic Atrial Fibrillation: Current Evidence and Unsolved Questions in Clinical Practice , 2019, Medicina.

[8]  Calvin E. Hwang Calculated Decisions: HAS-BLED Score for Major Bleeding Risk , 2019, Emergency medicine practice.

[9]  Hugh Calkins,et al.  Correction to: 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. , 2019, Circulation.

[10]  Hugh Calkins,et al.  2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. , 2019, Heart rhythm.

[11]  Hugh Calkins,et al.  2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. , 2019, Journal of the American College of Cardiology.

[12]  P. Noseworthy,et al.  Comparison of the CHA2DS2-VASc, CHADS2, HAS-BLED, ORBIT, and ATRIA Risk Scores in Predicting Non-Vitamin K Antagonist Oral Anticoagulants-Associated Bleeding in Patients With Atrial Fibrillation. , 2017, The American journal of cardiology.

[13]  D. Stewart,et al.  Optimizing the use of oral anticoagulant therapy for atrial fibrilation in primary care: a pharmacist-led intervention , 2017, International Journal of Clinical Pharmacy.

[14]  Emily P Zeitler,et al.  Remote monitoring of cardiac implantable electronic devices (CIED). , 2016, Trends in cardiovascular medicine.

[15]  J. Piccini,et al.  Preventing Stroke in Patients With Atrial Fibrillation-A Steep Climb Away From Achieving Peak Performance. , 2016, JAMA cardiology.

[16]  P. Kirchhof,et al.  Primary Care Atrial Fibrillation Service: outcomes from consultant-led anticoagulation assessment clinics in the primary care setting in the UK , 2015, BMJ Open.

[17]  P. Gorelick,et al.  HRS/NSA 2014 Survey of Atrial Fibrillation and Stroke: Gaps in Knowledge and Perspective, Opportunities for Improvement. , 2015, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[18]  G. Lip,et al.  Optimising stroke prevention in patients with atrial fibrillation: application of the GRASP-AF audit tool in a UK general practice cohort. , 2015, The British journal of general practice : the journal of the Royal College of General Practitioners.

[19]  D. Singer,et al.  Risks and Benefits of Anticoagulation in Atrial Fibrillation: Insights From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Registry , 2013, Circulation. Cardiovascular quality and outcomes.

[20]  M. Fang,et al.  Assessing bleeding risk in patients taking anticoagulants , 2013, Journal of Thrombosis and Thrombolysis.

[21]  K. Furie,et al.  Statin Therapy and Outcome After Ischemic Stroke: Systematic Review and Meta-Analysis of Observational Studies and Randomized Trials , 2013, Stroke.

[22]  Kelly M. Rudd,et al.  Comparison of Two Different Models of Anticoagulation Management Services with Usual Medical Care , 2010, Pharmacotherapy.

[23]  S. Lakhan,et al.  Blood pressure lowering treatment for preventing stroke recurrence: a systematic review and meta-analysis , 2009, International archives of medicine.

[24]  Chunliu Zhan,et al.  Cardiac Device Implantation in the United States from 1997 through 2004: A Population-based Analysis , 2007, Journal of General Internal Medicine.

[25]  L. Till,et al.  Assessment of Clinical Pharmacist Management of Lipid-Lowering Therapy in a Primary Care Setting , 2003, Journal of managed care pharmacy : JMCP.

[26]  E. Vivian Improving Blood Pressure Control in a Pharmacist‐Managed Hypertension Clinic , 2002, Pharmacotherapy.

[27]  Guy E. Thwaites,et al.  The Diagnosis and Management of Tuberculous Meningitis , 2002, Practical Neurology.